Published in Malar J on September 05, 2014
Mouse Models of Uncomplicated and Fatal Malaria. Bio Protoc (2015) 0.77
Myeloid expression of the AP-1 transcription factor JUNB modulates outcomes of type 1 and type 2 parasitic infections. Parasite Immunol (2015) 0.75
Blood-stage malaria of Plasmodium chabaudi induces differential Tlr expression in the liver of susceptible and vaccination-protected Balb/c mice. Parasitol Res (2016) 0.75
Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am J Pathol (1985) 7.14
The murine cerebral malaria phenomenon. Trends Parasitol (2009) 5.62
TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science (2005) 4.86
Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy. Am J Trop Med Hyg (2001) 4.83
Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases. Nat Rev Immunol (2008) 4.12
Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J Exp Med (2005) 3.85
Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc Natl Acad Sci U S A (2007) 3.41
Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol (2003) 3.18
Neurological sequelae of cerebral malaria in children. Lancet (1990) 3.11
Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. Proc Natl Acad Sci U S A (1989) 3.03
Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway. J Immunol (2004) 2.33
Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism. Nat Rev Immunol (2006) 2.24
Protein-DNA complex is the exclusive malaria parasite component that activates dendritic cells and triggers innate immune responses. J Immunol (2010) 2.09
Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J Immunol (1996) 2.07
Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India. Malar J (2008) 2.00
Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatr Res (2010) 1.98
Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection. J Immunol (2006) 1.94
Vascular clogging, mononuclear cell margination, and enhanced vascular permeability in the pathogenesis of human cerebral malaria. Am J Trop Med Hyg (1994) 1.91
Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease. Parasitology (2009) 1.87
Residual neurologic sequelae after childhood cerebral malaria. J Pediatr (1997) 1.84
Malaria: mechanisms of erythrocytic infection and pathological correlates of severe disease. Annu Rev Pathol (2007) 1.83
Profiles of cytokine production in relation with susceptibility to cerebral malaria. J Immunol (1993) 1.77
The role of animal models for research on severe malaria. PLoS Pathog (2012) 1.76
Interleukin-10 modulates susceptibility in experimental cerebral malaria. Immunology (1997) 1.73
Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria. Am J Trop Med Hyg (2008) 1.69
Pathological role of Toll-like receptor signaling in cerebral malaria. Int Immunol (2006) 1.66
Plasma interleukin-10:Tumor necrosis factor (TNF)-alpha ratio is associated with TNF promoter variants and predicts malarial complications. J Infect Dis (2000) 1.64
The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. J Infect Dis (1996) 1.62
Clusters of cytokines determine malaria severity in Plasmodium falciparum-infected patients from endemic areas of Central India. J Infect Dis (2006) 1.57
Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing. J Exp Med (2009) 1.53
Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria. Proc Natl Acad Sci U S A (2011) 1.44
Parasite-derived plasma microparticles contribute significantly to malaria infection-induced inflammation through potent macrophage stimulation. PLoS Pathog (2010) 1.39
Murine cerebral malaria development is independent of toll-like receptor signaling. Am J Pathol (2007) 1.38
The relevance of non-human primate and rodent malaria models for humans. Malar J (2011) 1.36
Delayed cerebellar ataxia complicating falciparum malaria: a clinical study of 74 patients. J Neurol (1994) 1.34
Tumor necrosis factor alpha in the pathogenesis of cerebral malaria. Cell Mol Life Sci (2003) 1.29
Toll-like receptor modulation of murine cerebral malaria is dependent on the genetic background of the host. J Infect Dis (2007) 1.25
Neuropathogenesis of human and murine malaria. Trends Parasitol (2010) 1.24
The burden of the neurocognitive impairment associated with Plasmodium falciparum malaria in sub-saharan Africa. Am J Trop Med Hyg (2004) 1.24
Retracted Interferon-gamma is essential for the development of cerebral malaria. Eur J Immunol (1997) 1.23
MyD88-dependent activation of dendritic cells and CD4(+) T lymphocytes mediates symptoms, but is not required for the immunological control of parasites during rodent malaria. Microbes Infect (2007) 1.23
Cytokines in the pathogenesis of and protection against malaria. Clin Diagn Lab Immunol (2002) 1.20
Recognition of Borrelia burgdorferi, the Lyme disease spirochete, by TLR7 and TLR9 induces a type I IFN response by human immune cells. J Immunol (2009) 1.18
Murine AIDS protects mice against experimental cerebral malaria: down-regulation by interleukin 10 of a T-helper type 1 CD4+ cell-mediated pathology. Proc Natl Acad Sci U S A (1994) 1.12
Rethinking cerebral malaria pathology. Curr Opin Infect Dis (2010) 1.06
Induction of experimental cerebral malaria is independent of TLR2/4/9. Med Microbiol Immunol (2007) 1.06
TLR9 and MyD88 are crucial for the development of protective immunity to malaria. J Immunol (2012) 1.04
Caspase-1 activation of interleukin-1β (IL-1β) and IL-18 is dispensable for induction of experimental cerebral malaria. Infect Immun (2011) 1.02
Cerebral malaria: human versus mouse studies. Trends Parasitol (2010) 1.01
Genetic susceptibility to systemic lupus erythematosus protects against cerebral malaria in mice. Proc Natl Acad Sci U S A (2010) 1.00
The nucleosome (histone-DNA complex) is the TLR9-specific immunostimulatory component of Plasmodium falciparum that activates DCs. PLoS One (2011) 0.99
Gamma delta T-cell function in pathogenesis of cerebral malaria in mice infected with Plasmodium berghei ANKA. Infect Immun (1999) 0.97
Cerebral malaria: in praise of epistemes. Trends Parasitol (2010) 0.96
Relative levels of IL4 and IFN-gamma in complicated malaria: association with IL4 polymorphism and peripheral parasitemia. Acta Trop (2007) 0.91
Association of cytokine and Toll-like receptor gene polymorphisms with severe malaria in three regions of Cameroon. PLoS One (2013) 0.91
Beta interferon suppresses the development of experimental cerebral malaria. Infect Immun (2011) 0.91
Proinflammatory responses by glycosylphosphatidylinositols (GPIs) of Plasmodium falciparum are mainly mediated through the recognition of TLR2/TLR1. Exp Parasitol (2011) 0.90
Toll-like receptor 7 mediates early innate immune responses to malaria. Infect Immun (2013) 0.85
Differential interleukin-10 expression in interferon regulatory factor-1 deficient mice during Plasmodium berghei blood-stage infection. Parasite Immunol (2000) 0.82
Delayed cerebellar ataxia: A rare self limiting complication of plasmodium falciparum malaria. Adv Biomed Res (2013) 0.77
Caspase-11 protects against bacteria that escape the vacuole. Science (2013) 4.01
A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP. J Exp Med (2009) 2.92
Restriction of Legionella pneumophila growth in macrophages requires the concerted action of cytokine and Naip5/Ipaf signalling pathways. Cell Microbiol (2007) 1.65
Cytokines regulate beta-2-adrenergic receptor responsiveness in airway smooth muscle via multiple PKA- and EP2 receptor-dependent mechanisms. Biochemistry (2005) 1.23
IL-1α signaling initiates the inflammatory response to virulent Legionella pneumophila in vivo. J Immunol (2013) 1.08
Toll-like receptor 7 mediates early innate immune responses to malaria. Infect Immun (2013) 0.85
Correction: Macrophage Colony Stimulating Factor Derived from CD4+ T Cells Contributes to Control of a Blood-Borne Infection. PLoS Pathog (2017) 0.75
Genetic control of immune cell types in fungal disease. Proc Natl Acad Sci U S A (2010) 0.75